UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 907

Sortiert nach

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Journal of the American College of Cardiology, 2012-11, Vol.60 (20), p.2032-2040

2012

Volltextzugriff (PDF)

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Journal of clinical medicine, 2019-11, Vol.8 (11), p.2009

2019

Volltextzugriff (PDF)

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events

The New England journal of medicine, 2016-02, Vol.374 (7), p.625-635

2016

Volltextzugriff (PDF)

Protist Genetic Diversity in the Acidic Hydrothermal Environments of Lassen Volcanic National Park, USA

The Journal of eukaryotic microbiology, 2006-11, Vol.53 (6), p.420-431

2006

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia

British journal of haematology, 2019-03, Vol.184 (6), p.1058-1061

2019

Volltextzugriff (PDF)

Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia

Thrombosis and haemostasis, 2017, Vol.117 (3), p.580

2017

Volltextzugriff (PDF)

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.112 (3), p.589

2014

Volltextzugriff (PDF)

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Thrombosis research, 2014-09, Vol.134 (3), p.552-557

2014

Volltextzugriff (PDF)

Clinical trial conduct in special populations and developing regions: An overview of the DOVE study in pediatric patients with sickle cell disease

Contemporary clinical trials, 2018-01, Vol.64, p.88-94

2018

Volltextzugriff (PDF)

Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy

Pediatric blood & cancer, 2016-02, Vol.63 (2), p.299-305

2016

Volltextzugriff (PDF)

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.111 (5), p.943

2014

Volltextzugriff (PDF)

Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia

Clinical trials (London, England), 2017-12, Vol.14 (6), p.563-571

2017

Volltextzugriff (PDF)

TCT-142 Prasugrel 5 mg inhibits platelet GPIIb-IIIa and P-Selectin expression in the very elderly - Results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients

Journal of the American College of Cardiology, 2013-10, Vol.62 (18), p.B45-B45

2013

Volltextzugriff (PDF)

A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel

Platelets (Edinburgh), 2013-01, Vol.24 (1), p.15-25

2013

Volltextzugriff (PDF)

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Blood, 2016-12, Vol.128 (22), p.3653-3653

2016

Volltextzugriff (PDF)

Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study

Blood, 2016-12, Vol.128 (22), p.3654-3654

2016

Volltextzugriff (PDF)

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients: Results From the FEATHER Trial

Journal of the American College of Cardiology, 2012-11, Vol.60 (20), p.2032-2040

2012

Volltextzugriff (PDF)

Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

Journal of the American College of Cardiology, 2013, Vol.62 (7), p.577

2013

Volltextzugriff (PDF)

Comparison of Diagnostic Accuracy with Carbon Dioxide versus Iodinated Contrast Material in the Imaging of Hemodialysis Access Fistulas

Journal of vascular and interventional radiology, 1994-09, Vol.5 (5), p.771-775

1994

Volltextzugriff (PDF)

Arts -- The New Dolls' House Do-It-Yourself Book in 1/12 and 1/16 Scale by Venus Dodge and Martin Dodge

Library Journal, 1993, Vol.118 (21), p.120

Brown, Patricia B

1993

Volltextzugriff (PDF)

The Complete Dolls' House Book

Library Journal, 1993, Vol.118 (19), p.76

Brown, Patricia B

1993

Volltextzugriff (PDF)

Arts -- The Complete Dolls' House Book by Jean Nisbett

Library Journal, 1993, Vol.118 (19), p.76

Brown, Patricia B

1993

Volltextzugriff (PDF)

Arts -- Dimensional Applique: Baskets, Blooms & Baltimore Borders by Elly Sienkiewicz

Library Journal, 1993, Vol.118 (17), p.65

Brown, Patricia B

1993

Volltextzugriff (PDF)

1 – 25 von 907

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(816)
Mit Volltextzugriff
(730)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events

Protist Genetic Diversity in the Acidic Hydrothermal Environments of Lassen Volcanic National Park, USA

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia

Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Clinical trial conduct in special populations and developing regions: An overview of the DOVE study in pediatric patients with sickle cell disease

Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia

TCT-142 Prasugrel 5 mg inhibits platelet GPIIb-IIIa and P-Selectin expression in the very elderly - Results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients

A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients: Results From the FEATHER Trial

Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

Comparison of Diagnostic Accuracy with Carbon Dioxide versus Iodinated Contrast Material in the Imaging of Hemodialysis Access Fistulas

Arts -- The New Dolls' House Do-It-Yourself Book in 1/12 and 1/16 Scale by Venus Dodge and Martin Dodge

The Complete Dolls' House Book

Arts -- The Complete Dolls' House Book by Jean Nisbett

Arts -- Dimensional Applique: Baskets, Blooms & Baltimore Borders by Elly Sienkiewicz

Suchergebnisse filtern